Although in breast cancer research, FAM96B has been reported to inhibit cancer progression by regulating the Wnt/β-catenin signaling pathway,18 its specific mechanism of action in HCC remains unclear. This evidence concerns the gene CIAO2B and hepatocellular carcinoma.